Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 28% ± 10% | |
lung | 15 studies | 37% ± 13% | |
intestine | 12 studies | 26% ± 12% | |
kidney | 8 studies | 31% ± 9% | |
eye | 7 studies | 29% ± 14% | |
liver | 5 studies | 31% ± 19% | |
brain | 5 studies | 22% ± 7% | |
pancreas | 4 studies | 57% ± 19% | |
placenta | 4 studies | 35% ± 17% | |
bone marrow | 4 studies | 20% ± 3% | |
uterus | 4 studies | 43% ± 16% | |
lymph node | 4 studies | 26% ± 13% | |
breast | 4 studies | 29% ± 4% | |
adrenal gland | 3 studies | 21% ± 3% | |
prostate | 3 studies | 31% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 6749.55 | 258 / 258 | 100% | 195.86 | 230 / 230 |
ovary | 100% | 3793.61 | 180 / 180 | 100% | 121.82 | 430 / 430 |
skin | 100% | 5364.49 | 1809 / 1809 | 100% | 202.68 | 472 / 472 |
thymus | 100% | 5096.13 | 653 / 653 | 100% | 265.55 | 605 / 605 |
brain | 100% | 4432.89 | 2641 / 2642 | 100% | 184.33 | 705 / 705 |
kidney | 100% | 5433.66 | 89 / 89 | 100% | 192.26 | 900 / 901 |
uterus | 100% | 4169.02 | 170 / 170 | 100% | 205.59 | 458 / 459 |
liver | 100% | 3224.33 | 225 / 226 | 100% | 187.32 | 406 / 406 |
esophagus | 100% | 4956.60 | 1445 / 1445 | 99% | 100.36 | 182 / 183 |
intestine | 100% | 5019.66 | 966 / 966 | 99% | 163.18 | 524 / 527 |
stomach | 100% | 4207.79 | 359 / 359 | 99% | 138.12 | 284 / 286 |
prostate | 100% | 4525.29 | 245 / 245 | 99% | 219.65 | 498 / 502 |
lung | 100% | 4611.18 | 578 / 578 | 99% | 152.50 | 1142 / 1155 |
pancreas | 99% | 2619.85 | 326 / 328 | 99% | 201.73 | 177 / 178 |
bladder | 100% | 4394.00 | 21 / 21 | 99% | 193.78 | 497 / 504 |
breast | 100% | 4856.20 | 459 / 459 | 98% | 207.80 | 1101 / 1118 |
adipose | 100% | 4861.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 233.30 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 254.17 | 29 / 29 |
muscle | 100% | 4810.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4603.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 181.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 169.91 | 1 / 1 |
blood vessel | 100% | 5177.76 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 8131.14 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 4010.76 | 852 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051260 | Biological process | protein homooligomerization |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0045184 | Biological process | establishment of protein localization |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0045324 | Biological process | late endosome to vacuole transport |
GO_0010324 | Biological process | membrane invagination |
GO_0016236 | Biological process | macroautophagy |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0051258 | Biological process | protein polymerization |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_0010458 | Biological process | exit from mitosis |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0032509 | Biological process | endosome transport via multivesicular body sorting pathway |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0019076 | Biological process | viral release from host cell |
GO_1904903 | Biological process | ESCRT III complex disassembly |
GO_1903723 | Biological process | negative regulation of centriole elongation |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0030117 | Cellular component | membrane coat |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0000785 | Cellular component | chromatin |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP2A |
Protein name | Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1) |
Synonyms | CHMP2 BC2 |
Description | FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis . Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase . Recruited to the reforming nuclear envelope (NE) during anaphase by LEMD2 . ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. .; FUNCTION: (Microbial infection) The ESCRT machinery functions in topologically equivalent membrane fission events, such as the budding of enveloped viruses (HIV-1 and other lentiviruses). Involved in HIV-1 p6- and p9-dependent virus release. . |
Accessions | ENST00000597848 M0R1T5 M0QXX8 ENST00000600006.6 ENST00000596708 O43633 ENST00000312547.7 M0R1L7 ENST00000601220.5 ENST00000597848.2 ENST00000600118.6 ENST00000596708.2 |